Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

Share Price is delayed by 15 minutes
Get Live Data
1,020.00    14.00 (1.39%)
Bid:
1,028.00
Ask:
1,032.00
Spread: 4.00 (0.389%)
Market Cap: £146.15b
BNC Live PriceLast checked at - London Stock Exchange

Intraday Banco Santander Share Chart

Buyback programme: transactions 12 - 18 January

19 Jan 2023 11:14

RNS Number : 2888N
Banco Santander S.A.
19 January 2023
 

Banco Santander, S.A. (the "Bank" or "Banco Santander"), in compliance with the Securities Market legislation, hereby communicates the following:

OTHER RELEVANT INFORMATION

 

Reference is made to our notice of inside information of 21 November 2022 (official registry number 1669), relating to the buyback programme of own shares (the "Buy-back Programme") approved by the Board of Directors of Banco Santander.

Pursuant to article 5 of Regulation (EU) no. 596/2014 on Market Abuse of 16 April 2014, and articles 2.2 and 2.3 of Commission Delegated Regulation (EU) 2016/1052, of 8 March 2016, the Bank informs, on the basis of the information received from Goldman Sachs International as intermediary in charge of executing the Buy-back Programme, that it has carried out the following transactions over its own shares between 12 and 18 January 2023 (both inclusive):

 

Date

Security

Transaction

Trading venue

Number of shares

Weighted average price (€)

12/01/2023

SAN

Purchase

XMAD

462,845

3.0831

13/01/2023

SAN

Purchase

XMAD

7,500,000

3.1337

13/01/2023

SAN

Purchase

CEUX

2,500,000

3.1313

16/01/2023

SAN

Purchase

XMAD

1,188,933

3.1091

17/01/2023

SAN

Purchase

XMAD

7,066,389

3.1059

17/01/2023

SAN

Purchase

CEUX

3,500,000

3.1051

18/01/2023

SAN

Purchase

XMAD

5,000,000

3.1426

18/01/2023

SAN

Purchase

CEUX

2,000,000

3.1417

TOTAL

29,218,167

 

 

Issuer name: Banco Santander, S.A. - LEI 5493006QMFDDMYWIAM13

 

Reference of the financial instrument: ordinary shares - Code ISIN ES0113900J37

Detailed information of the transactions carried out within the referred period is attached as Annex I.

 

Boadilla del Monte (Madrid), 19 January 2023

ANNEX I

Detailed information on each of the transactions carried out within the context of the Buy-back Programme between 12/01/2023 and 18/01/2023 (both inclusive)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSMZGMMMLFGFZM
Date   Source Headline
22nd Oct 202511:11 amRNSThird Quarter 2025 Results Notice
16th Oct 202511:12 amRNSBuyback programme: transactions 9-15Oct
9th Oct 202511:05 amRNSBuyback programme: transactions 2-8Oct
3rd Oct 20252:58 pmRNSMoody's has upgraded Santanders rating
2nd Oct 20255:15 pmRNSDirector/PDMR Shareholding
2nd Oct 202511:07 amRNSBuyback programme: Transactions 25Sept-1Oct
30th Sep 20252:23 pmRNSDividend approval
30th Sep 202511:56 amRNSTotal Voting Rights
25th Sep 202511:12 amRNSBuyback programme: transactions 18-24Sept
18th Sep 202511:04 amRNSBuyback programme: transactions 11-17Sept
11th Sep 20254:54 pmRNSDirector/PDMR Shareholding
11th Sep 202511:07 amRNSBuyback programme: transactions 4-10Sept
4th Sep 202511:04 amRNSBuyback programme: transactions 28Aug-3Sept
29th Aug 20254:35 pmRNSTotal Voting Rights
29th Aug 202511:34 amRNSModification of internationalization covered bonds
28th Aug 202511:04 amRNSBuyback programme: transactions 21-27Aug
21st Aug 202511:04 amRNSBuyback programme: transactions 14-20Aug
14th Aug 202511:08 amRNSBuyback programme: transactions 7-13Aug
11th Aug 202511:09 amRNSDirector/PDMR Shareholding
7th Aug 202511:09 amRNSBuyback programme: transactions 31Jul - 6Aug
1st Aug 20255:48 pmRNSStress test Results
31st Jul 20254:57 pmRNSTotal Voting Rights
31st Jul 202512:07 pmRNSHalf-year Report
30th Jul 20257:00 amRNS1st Half 25 results report & earnings presentation
30th Jul 20257:00 amRNSFirst Half 2025 Results - Press release
30th Jul 20257:00 amRNSCommencement of a program to repurchase own shares
23rd Jul 202511:11 amRNSNotice of First Half 2025 Results
2nd Jul 20257:00 amRNSPresentation to analysts about transaction on TSB
1st Jul 20256:20 pmRNSSantander to acquire TSB. Analysts meeting notice
1st Jul 20252:55 pmRNSInvitation to buy outstanding preferred securities
30th Jun 202511:55 amRNSTotal Voting Rights
27th Jun 20254:49 pmRNSDirector/PDMR Shareholding
27th Jun 20254:47 pmRNSDirector/PDMR Shareholding
25th Jun 20257:00 amRNSInvitation to buy outstanding preferred securities
24th Jun 20257:48 amRNSInvitation to buy outstanding preferred securities
20th Jun 20255:16 pmRNSDirector/PDMR Shareholding
10th Jun 20253:54 pmRNSFurther re Capital reduction
10th Jun 20253:36 pmRNSDirector/PDMR Shareholding
3rd Jun 20252:38 pmRNSTotal Voting Rights
3rd Jun 202510:00 amRNSCapital reduction following completion of program
2nd Jun 202512:08 pmRNSTotal Voting Rights
29th May 202511:12 amRNSBuyback programme: transactions 22-28May
22nd May 202511:05 amRNSBuyback programme: transactions 14-21May
21st May 202512:41 pmRNSDirector/PDMR Shareholding
20th May 202512:57 pmRNSDirector/PDMR Shareholding
14th May 20255:36 pmRNSDirector/PDMR Shareholding
14th May 20253:33 pmRNSBuyback programme: transactions 7-13May
13th May 20254:11 pmRNSDirector/PDMR Shareholding
9th May 20251:17 pmRNSDirector/PDMR Shareholding
9th May 20251:10 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.